Pictet Asset Management (Switzerland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $67M | Sell |
1,047,007
-16,325
| -2% | -$1.04M | 0.08% | 254 |
|
|
2023
Q1 | $73.7M | Buy |
1,063,332
+19,516
| +2% | +$1.35M | 0.09% | 232 |
|
|
2022
Q4 | $64.6M | Buy |
1,043,816
+21,926
| +2% | +$1.36M | 0.09% | 234 |
|
|
2022
Q3 | $72.6M | Sell |
1,021,890
-13,160
| -1% | -$936K | 0.11% | 224 |
|
|
2022
Q2 | $79.7M | Sell |
1,035,050
-30,761
| -3% | -$2.37M | 0.11% | 217 |
|
|
2022
Q1 | $77.8M | Buy |
1,065,811
+26,121
| +3% | +$1.91M | 0.09% | 250 |
|
|
2021
Q4 | $64.8M | Buy |
1,039,690
+10,562
| +1% | +$659K | 0.06% | 300 |
|
|
2021
Q3 | $60.9M | Buy |
+1,029,128
| New | +$60.9M | 0.07% | 299 |
|